T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
复制标题
作者:
Interferon-β is the major treatment for multiple sclerosis (MS). However, this treatment is not always effective. Here we see congruence in outcome between responses to IFN-β in experimental autoimmune encephalomyelitis (EAE) and relapsing-remitting MS (RRMS). IFN-β is effective in reducing EAE induced by TH1 cells, but exacerbated disease induced by TH17. Effective treatment in TH1 EAE correlated with increased IL-10 in the spleen. In TH17 disease, the amount of IL-10 was unaltered by treatment, though unexpectedly IFN-β still reduced IL-17 without benefit. Both inhibition of IL-17 and induction of IL-10 depended on IFN-γ. In the absence of IFN-γ signaling, IFN-β therapy was ineffective in EAE. In RRMS, IFN-β non-responders had higher IL-17F in serum compared to responders. Non-responders had worse disease with more steroid usage and more relapses than responders. Hence, IFN-β is pro-inflammatory in TH17 induced EAE. Moreover, high IL-17F in the serum of RRMS patients is associated with non-responsiveness to therapy with IFN-β.
登录
查看更多内容
影响因子:
30.5
作者:
Nguyen, KB;Cousens, LP;Biron, CA
通讯作者:
Biron, CA
影响因子:
15.9
作者:
Haak, Stefan;Croxford, Andrew L.;Waisman, Ari
通讯作者:
Waisman, Ari
影响因子:
4.4
作者:
Tanabe, Y;Nishibori, T;David, M
通讯作者:
David, M
影响因子:
3.6
作者:
Martin-Saavedra, Francisco M.;Gonzalez-Garcia, Coral;Ballester, Sara
通讯作者:
Ballester, Sara
影响因子:
3.3
作者:
Graber, Jerome J.;Ford, David;Dhib-Jalbut, Suhayl
通讯作者:
Dhib-Jalbut, Suhayl